Fanglin Lu
Impact in
-
- Cardiac Valve Diseases and Treatments
- Genetics top 5%
- Mesenchymal stem cell research
Papers in
-
- Cardiac Valve Diseases and Treatments 37
- Cardiovascular Function and Risk Factors 11
-
- Aortic Disease and Treatment Approaches 19
- Aortic aneurysm repair treatments 9
- Co-authors
- Zhiyun XuYutaka SakakibaraMasashi KomedaKeiichi TambaraKazunobu NishimuraLin HanShengdong HuangGenichi Sakaguchi
- Journals
- Journal of Thoracic and Cardiovascular Surgery (7 papers)International Journal of Cardiology (4 papers)The Annals of Thoracic Surgery (4 papers)The Heart Surgery Forum (2 papers)Circulation (2 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Fanglin Lu
70 papers receiving 946 citations
Peers
Comparison fields: 5 of 89
- Cardiology and Cardiovascular Medicine 387
- Genetics 160
- Biomaterials 164
- Surgery 411
- Pulmonary and Respiratory Medicine 231
Countries citing papers authored by Fanglin Lu
This map shows the geographic impact of Fanglin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanglin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanglin Lu more than expected).
Fields of papers citing papers by Fanglin Lu
This network shows the impact of papers produced by Fanglin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanglin Lu. The network helps show where Fanglin Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fanglin Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 10 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 0 | |
| 9 | 2021 | 16 | |
| 10 | 2020 | 10 | |
| 11 | 2019 | 6 | |
| 12 | 2018 | 1 | |
| 13 | 2018 | 7 | |
| 14 | 2017 | 30 | |
| 15 | 2017 | 4 | |
| 16 | 2012 | 4 | |
| 17 | MiR-203 inhibits proliferation and invasion of esophageal squamous cell carcinoma | 2010 | 1 |
| 18 | 2009 | 30 | |
| 19 | 2003 | 17 | |
| 20 | 2002 | 107 |
About Fanglin Lu
Fanglin Lu is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Epidemiology, Biomaterials and Surgery, having authored 79 papers that have together received 973 indexed citations. Recurring topics across this work include Cardiac Valve Diseases and Treatments (37 papers), Infective Endocarditis Diagnosis and Management (21 papers), Aortic Disease and Treatment Approaches (19 papers), Cardiovascular Function and Risk Factors (11 papers), Cardiac Structural Anomalies and Repair (10 papers), Aortic aneurysm repair treatments (9 papers), Mechanical Circulatory Support Devices (8 papers) and Tissue Engineering and Regenerative Medicine (7 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (387 citations), Genetics (160 citations), Biomaterials (164 citations), Surgery (411 citations) and Pulmonary and Respiratory Medicine (231 citations). Fanglin Lu has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Zhiyun Xu, Yutaka Sakakibara, Masashi Komeda, Keiichi Tambara, Kazunobu Nishimura, Lin Han, Shengdong Huang, Genichi Sakaguchi, Zhigang Song and Zhiyun Xu. Their work appears in journals such as Journal of Thoracic and Cardiovascular Surgery, International Journal of Cardiology, The Annals of Thoracic Surgery, The Heart Surgery Forum and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.